From the Literature

Published: Sep 2015

Bhandari S, Kalra PA, Kothari J, et al.

A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
Nephrol Dial Transplant 2015;30:1577-1589.

#

NATA REVIEW:
There is a lack of universal consensus among nephrologists and haematologists on several core issues pertaining...
REVIEW by:
M. Muñoz

Published: Sep 2015

Likosky DS, Paone G, Zhang M, et al.

Red blood cell transfusions impact pneumonia rates after coronary artery bypass grafting.
Ann Thorac Surg 2015;100:794-801.

#

NATA REVIEW:
Dr. Likosky and colleagues report a retrospective analysis of more than 16,000 patients undergoing coronary...
REVIEW by:
C. von Heymann

Published: Sep 2015

Ferraris VA, Hochstetler M, Martin JT, Mahan A, Saha SP

Blood transfusion and adverse surgical outcomes: The good and the bad.
Surgery 2015;158:608-617.

#

NATA REVIEW:
In this article, Ferraris and coworkers attempt to identify patient characteristics that can differentiate patients...
REVIEW by:
O. Habler

Published: Sep 2015

McKinney ZJ, Peters JM, Gorlin JB, Perry EH

Improving red blood cell orders, utilization, and management with point-of-care clinical decision support.
Transfusion 2015;55:2086-2094.

#

NATA REVIEW:
Praise for a method that implements the single-unit order! Almost all over the world, the old doctrine...
REVIEW by:
T. Frietsch

Published: Sep 2015

Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ, Pendry K

A practical guideline for the haematological management of major haemorrhage.
Br J Haematol 2015;170:788-803.

#

NATA REVIEW:
Hunt et al. set the standards in a practical guideline from the British Committee for Standards in Haematology....
REVIEW by:
J. Stensballe

Published: Aug 2015

Douketis JD, Spyropoulos AC, Kaatz S, et al.

Perioperative bridging anticoagulation in patients with atrial fibrillation.
N Engl J Med 2015;373:823-833.

#

NATA REVIEW:
Perioperative management of anticoagulation is sometimes complex and challenging. Different factors influencing...
REVIEW by:
D. Faraoni

Published: Aug 2015

Pollack CV, Jr., Reilly PA, Eikelboom J, et al.

Idarucizumab for dabigatran reversal.
N Engl J Med 2015;373:511-520.

#

NATA REVIEW:
Dabigatran etexilate, a direct thrombin inhibitor, has been increasingly used over the last few years, but the...
REVIEW by:
D. Faraoni

Published: Aug 2015

Glund S, Stangier J, Schmohl M, et al.

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
Lancet 2015;386:680-690.

#

NATA REVIEW:
Dabigatran etexilate is a direct thrombin inhibitor increasingly used for stroke prevention in patients with...
REVIEW by:
D. Faraoni

Published: Aug 2015

Caldeira D, Rodrigues FB, Barra M, et al.

Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
Heart 2015;101:1204-1211.

#

NATA REVIEW:
Non-vitamin K antagonist oral anticoagulants (NOACs) are alternatives to vitamin K antagonists (VKAs) for the...
REVIEW by:
F. Bonhomme

Published: Aug 2015

Butler CE, Noel S, Hibbs SP, et al.

Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients.
Transfusion 2015;55:1964-1971.

#

NATA REVIEW:
The authors report the impact of a clinical decision support system at a single centre to improve transfusion...
REVIEW by:
L. T. Goodnough

Pages